Breaking News Instant updates and real-time market news.

CORT

Corcept Therapeutics

$14.00

-0.08 (-0.57%)

16:27
08/09/18
08/09
16:27
08/09/18
16:27

Corcept Therapeutics reports Q2 EPS 20c, consensus 24c

Reports Q2 revenue $62.3M, consensus $68.5M.Cash and investments were $159.9 million at June 30, 2018, an increase of $19.6 million from first quarter 2018.

  • 09

    Aug

  • 04

    Sep

CORT Corcept Therapeutics
$14.00

-0.08 (-0.57%)

04/13/18
GHSC
04/13/18
INITIATION
Target $32
GHSC
Buy
Corcept Therapeutics initiated with a Buy at Seaport Global
Seaport Global analyst Corey Davis initiated Corcept Therapeutics with a Buy and $32 price target citing long-term organic growth, Korlym remains underpenetrated in Cushing's syndrome, low consensus estimates, and upcoming relacorilant final Phase 2 data in Q3 that could act as a major catalyst.
05/31/18
STFL
05/31/18
DOWNGRADE
STFL
Hold
Corcept Therapeutics downgraded to Hold from Buy at Stifel
05/31/18
05/31/18
DOWNGRADE
Target $20

Hold
Corcept Therapeutics downgraded to Hold ahead of competitive read outs at Stifel
As previously reported, Stifel analyst Adam Walsh downgraded Corcept Therapeutics (CORT) to Hold from Buy, noting that results are due near-term for both Strongbridge Biopharma's (SBBP) Recorlev and Novartis' (NVS) osilodrostat. While he does not have a clear read on the potential for positive outcomes for these candidates, Walsh thinks the impending read outs could create an overhang for Corcept shares, he tells investors. The analyst, who also notes a lack of FDA clarity on the Phase 3 trial design for Corcept's second-gen Cushing's candidate relacorilant, keeps a $20 price target on Corcept shares.
05/31/18
05/31/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Paccar (PCAR) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revich saying that while U.S. truck spot market indicators have stabilized at new cycle highs amid robust freight demand and a tight trucking labor market, the load-truck ratio - a leading indicator - has declined about 30% over the past 4 months. 2. MAA (MAA) downgraded to Neutral from Buy at BTIG with analyst James Sullivan saying he expects lower relative valuations for Apartment REITs following the "mediocre" quarterly results. 3. Micron (MU) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Joseph Moore saying he believes the continued strength in DRAM looks priced in and the NAND recovery that bulls are looking for in the second half of the year looks "increasingly unlikely." 4. Corcept Therapeutics (CORT) downgraded to Hold from Buy at Stifel with analyst Adam Walsh saying results are due near-term for both Strongbridge Biopharma's (SBBP) Recorlev and Novartis' (NVS) osilodrostat. 5. DSW (DSW) downgraded to Neutral from Positive at Susquehanna with analyst Sam Poser citing limited valuation upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ECYT

Endocyte

$15.55

-0.4 (-2.51%)

, NVS

Novartis

$85.34

-0.41 (-0.48%)

09:16
10/18/18
10/18
09:16
10/18/18
09:16
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$15.55

-0.4 (-2.51%)

NVS

Novartis

$85.34

-0.41 (-0.48%)

ACOR

Acorda Therapeutics

$19.19

-0.7 (-3.52%)

PM

Philip Morris

$84.62

1.12 (1.34%)

AA

Alcoa

$36.71

0.51 (1.41%)

ERIC

Ericsson

$8.74

0.11 (1.27%)

SAP

SAP

$115.86

-1.56 (-1.33%)

TXT

Textron

$64.72

-2.01 (-3.01%)

SEE

Sealed Air

$35.28

-0.12 (-0.34%)

URI

United Rentals

$139.04

-2.15 (-1.52%)

ACRS

Aclaris Therapeutics

$12.14

-0.29 (-2.33%)

ADI

Analog Devices

$85.27

-0.48 (-0.56%)

MXIM

Maxim Integrated

$52.84

-0.13 (-0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 07

    Nov

  • 27

    Nov

  • 05

    Jan

  • 18

    Oct

CSLT

Castlight Health

$2.62

0.04 (1.55%)

09:15
10/18/18
10/18
09:15
10/18/18
09:15
Recommendations
Castlight Health analyst commentary  »

William Blair sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

DTRM

Determine

$0.58

-0.01 (-1.69%)

09:14
10/18/18
10/18
09:14
10/18/18
09:14
Hot Stocks
GTT choses Determine's procure-to-pay solution »

Determine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACW

PacWest Bancorp

$44.20

-0.14 (-0.32%)

09:13
10/18/18
10/18
09:13
10/18/18
09:13
Recommendations
PacWest Bancorp analyst commentary  »

PacWest Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PM

Philip Morris

$84.62

1.12 (1.34%)

09:13
10/18/18
10/18
09:13
10/18/18
09:13
Hot Stocks
Philip Morris says KFDA comments impacting those new to IQOS »

Says KFDA comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ATOM

Atomera

$4.65

(0.00%)

09:12
10/18/18
10/18
09:12
10/18/18
09:12
Initiation
Atomera initiated  »

Atomera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

CGIX

Cancer Genetics

$0.82

0.01 (1.23%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
Cancer Genetics enters strategic partnership with Genecast Biotechnology »

Cancer Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BL

BlackLine

$45.55

-0.01 (-0.02%)

, TRUE

TrueCar

$12.14

-0.1 (-0.82%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
BlackLine names Susan Otto as chief people officer »

BlackLine (BL) announced…

BL

BlackLine

$45.55

-0.01 (-0.02%)

TRUE

TrueCar

$12.14

-0.1 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 13

    Nov

CCB

Coastal Financial

$16.25

0.05 (0.31%)

09:10
10/18/18
10/18
09:10
10/18/18
09:10
Hot Stocks
Coastal Financial hires Erika Heer as CHRO »

Coastal Financial hired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:10
10/18/18
10/18
09:10
10/18/18
09:10
General news
Fed dove Bullard said monetary policy is about right »

Fed dove Bullard said…

09:10
10/18/18
10/18
09:10
10/18/18
09:10
General news
The Philly Fed slipped to 22.2 »

The Philly Fed slipped to…

SPN

Superior Energy

$9.62

-0.25 (-2.53%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PM

Philip Morris

$84.62

1.12 (1.34%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Hot Stocks
Philip Morris sees Q4 net revenue down about 5%, reflecting difficult comps »

Says September YTD net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

IBM

IBM

$134.05

-10.97 (-7.56%)

, LNVGY

Lenovo

$0.00

(0.00%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Hot Stocks
IBM signs $240M agreement with Lenovo for AI call center technology »

IBM (IBM) will supply…

IBM

IBM

$134.05

-10.97 (-7.56%)

LNVGY

Lenovo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 13

    Nov

  • 03

    Mar

TMO

Thermo Fisher

$234.64

-0.59 (-0.25%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Thermo Fisher rating change  »

Thermo Fisher downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 24

    Oct

HAL

Halliburton

$39.56

-0.52 (-1.30%)

09:09
10/18/18
10/18
09:09
10/18/18
09:09
Downgrade
Halliburton rating change  »

Halliburton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

STIM

Neuronetics

$22.50

-1.63 (-6.76%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Recommendations
Neuronetics analyst commentary  »

Neuronetics fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

KEY

KeyCorp

$18.75

0.17 (0.91%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Hot Stocks
KeyCorp sees Q4 average loans up low single digits »

Sees Q4 average deposits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 30

    Oct

  • 16

    Nov

SAN

Banco Santander

$4.90

-0.085 (-1.71%)

09:07
10/18/18
10/18
09:07
10/18/18
09:07
Periodicals
German probe into share-swapping scheme spreads to Santander, FT reports »

Spain's Banco…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$202.78

0.48 (0.24%)

09:05
10/18/18
10/18
09:05
10/18/18
09:05
Hot Stocks
Amgen invests $66M in Oxford Nanopore Technologies »

Amgen announced an equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 30

    Oct

  • 07

    Nov

  • 09

    Nov

FLS

Flowserve

$51.52

-0.29 (-0.56%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Downgrade
Flowserve rating change  »

Flowserve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XYL

Xylem

$71.34

-0.4 (-0.56%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Upgrade
Xylem rating change  »

Xylem upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

PNFP

Pinnacle Financial

$56.63

1.43 (2.59%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Recommendations
Pinnacle Financial analyst commentary  »

Pinnacle Financial price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 26

    Nov

NUE

Nucor

$59.11

0.17 (0.29%)

09:04
10/18/18
10/18
09:04
10/18/18
09:04
Earnings
Breaking Earnings news story on Nucor »

Nucor reports Q3 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NUE

Nucor

$59.11

0.17 (0.29%)

09:03
10/18/18
10/18
09:03
10/18/18
09:03
Hot Stocks
Nucor CEO: We are on pace for 2018 to be a record year for earnings »

"The strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.